StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.29−0.32 (-12.26%)

Close on Nov 16, 2026Market cap $10.23MP/E –Yield –

Bluejay Diagnostics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Bluejay Diagnostics's profit margin for the twelve months ending Dec 31, 2022 was -3733.1%. For fiscal 2022 it was -3733.1%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-3733.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2022Jun 30, 2022-777.9%–

More Bluejay Diagnostics figures

See a number that looks wrong?